Exposure to farmyard bugs reduces immune overreaction found in childhood asthma

September 24, 2018 by Ryan O'hare, Imperial College London
Exposure to farmyard microbes was already known to protect children from developing asthma, with studies of Amish families in the United States showing a link. The Imperial team has shown a mechanism by which these bugs may protect us from developing abnormal lung function in early life. Credit: Wikicommons / Ernest Mettendorf

Treating new born mice with farmyard microbes reduces wheezing and inflammation in the airways, by 'taming' their immune systems.

The findings, from a study recently published in the journal Science Immunology, reveal more about the mechanisms underlying hyperresponsiveness in the airways of the lungs – which causes wheezing and is a core component of childhood .

According to researchers, the work could lead to targeted treatments for young children which could ultimately help to curb childhood respiratory conditions, including asthma, and impaired function in adulthood.

The findings further highlight a 'window of opportunity' in early life in which the immature immune system can be shaped by the environment through exposure to allergens, such as dust and certain types of beneficial microbes.

Sejal Saglani, Professor of paediatric respiratory medicine at Imperial's National Heart & Lung Institute (NHLI), said: "Exposure to farmyard microbes was already known to protect children from developing asthma in epidemiological studies. While these studies showed a link, we have shown a mechanism by which they may protect us from developing abnormal in early life.

Professor Saglani added: "Our study looked at mice, but if we can find a way to replicate the effect in humans, we could potentially stop the immune system from 'overreacting' early on in life, catching the root cause of before it can gain a foothold."

Burden of asthma

Asthma affects an estimated 10 per cent of children in UK, causing breathlessness and can in severe cases disrupt work and leisure activities. When symptoms are triggered, attacks lead to the airways constricting, causing difficulty breathing and which, if untreated, can lead to hospitalisation.

One of the key features which develops in early childhood is wheezing. This is caused by hyperresponsiveness, where the small airways of the lungs become more sensitive to elements like dust, or allergen particles from animal hair or mites.

However, exactly why this process occurs is not well understood, and there are currently no treatments to prevent wheeze from developing.

In the latest study, researchers from Imperial College London looked to mice to try and uncover what was going on.

Animals were exposed to low levels of allergens from dust mites, similar to levels found in the average home, measuring the immune responses in the animals' airways.

The researchers also exposed new-born mice to a strain of common bacteria found on farmyards, Acinetobacter Iwoffii, for three weeks along with the dust mite allergen. Previous studies have found a link between reduced rates of asthma and exposure to farmyard microbes in humans, but how they have an effect on the lungs was unclear.

The team discovered that mice treated with the bacteria had reduced levels of an inflammatory marker called IL-13, produced by their T cells, and were completely protected from airway hyperresponsiveness, showing the microbes dampen down a key inflammatory pathway.

They also found that compared to adults, younger mice had greater activity in their T cells, which were more likely to cause an overreaction, resulting in inflammation and wheezing.

When exposed to the dust mite allergens, these cells pumped out IL-13, which kicked off the . But in knockout mice where these T cells were unable to produce IL-13, they found a greatly reduced immune response.

Other types of immune cells, more prevalent in adults and which produce the same marker, were unable to generate the same response in the airways, pointing to the T cells as the culprits for driving hyperresponsiveness in new-borns and infants.

Targeting T-cells

According to the group, the findings highlight the need to focus specifically on reducing the effect of T cells in infants to tackle the underlying mechanisms that lead to wheezing.

Professor Saglani said: "Wheezing disorders are common in children, particularly following viral infections, or colds, but some children go onto develop asthma by school age, and we can't predict which children, and why.

"Our findings show that there are key differences in the immune responses to allergens in young compared to adult , reinforcing the importance of age as an influence on immune pathways."

Professor Clare Lloyd, Vice-Dean (institutional affairs) of Imperial's National Heart & Lung Institute, who led the study, added: "A key clinical aspect of asthma in childhood is wheezing, which is caused by the narrowing of the small airways in the lungs, a process called bronchoconstriction.

"In order to develop new treatments for childhood wheezing we need to understand the underlying molecular mechanisms of this process and how it changes airway hyperresponsiveness."

"We now need to translate our findings and examine similar pathways in children with preschool wheeze," explained Professor Lloyd. "Ultimately, we would hope to be able to treat patients with a drug similar to the farmyard microbes to protect from wheezing and asthma."

Explore further: Obesity alters airway muscle function, increases asthma risk

More information: Sejal Saglani et al. Inception of early-life allergen–induced airway hyperresponsiveness is reliant on IL-13+CD4+ T cells, Science Immunology (2018). DOI: 10.1126/sciimmunol.aan4128

Related Stories

Obesity alters airway muscle function, increases asthma risk

September 13, 2018
New research suggests that obesity changes how airway muscles function, increasing the risk of developing asthma. The study is published ahead of print in the American Journal of Physiology—Lung Cellular and Molecular Physiology.

Research reveals possible new treatment pathway for severe allergic asthma

October 13, 2017
Research demonstrates that blocking the action of two pro-inflammatory molecules significantly reduces symptoms of allergic asthma in mice, which could lead to development of a new treatment for people with a severe form ...

Basophils are found to be key drivers of allergy-induced lung inflammation

July 25, 2014
Many particles and molecules in the environment can trigger allergic asthma in susceptible individuals. The allergic response to some of these allergens results in lung inflammation that can lead to a narrowing of the airways ...

Scientists discover peptide that could reduce the incidence of RSV-related asthma

February 1, 2017
A research report published in the Journal of Leukocyte Biology shows that it may one-day be possible to reduce the incidence of asthma related to infection with respiratory syncytial virus (RSV). Specifically, the researchers ...

New molecular target could help ease asthma

March 7, 2018
Researchers at UC Davis Health and Albany Medical College have shown that the protein vascular endothelial growth factor A—or VEGFA—plays a major role in the inflammation and airway obstruction associated with asthma.

Asthma differences in adults and children

March 22, 2018
As the winter cold season melts into seasonal spring allergies, many people may start to experience sneezing, wheezing and other breathing difficulties.

Recommended for you

Breastfeeding protects infants from antibiotic-resistant bacteria

October 18, 2018
A recent study completed at the University of Helsinki investigated the amount and quality of antibiotic-resistant bacteria in breast milk and gut of mother-infant pairs. The findings have been published in the journal Nature ...

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

New immunotherapy targeting blood-clotting protein

October 15, 2018
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Immune health maintained by meticulously ordered DNA

October 15, 2018
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organisation skills of a protein called Pax5.

Enzyme that triggers autoimmune responses from T-cells in patients with MS found

October 11, 2018
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.